郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study.

期刊：PloS one发表年份：2011作者：Isabel D Alves; Cherine Bechara; Astrid Walrant; Yefim Zaltsman; Chen-Yu Jiao; Sandrine Sagan
阅读更多 →

药效评价Effects of ranolazine on cloned cardiac kv4.3 potassium channels.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2011作者：Hee Jae Kim; Hye Sook Ahn; Jin Sung Choi; Bok Hee Choi; Sang June Hahn
阅读更多 →

药效评价Identification of novel and selective Kv2 channel inhibitors.

期刊：Molecular pharmacology发表年份：2011作者：James Herrington; Kelli Solly; Kevin S Ratliff; Nina Li; Yun-Ping Zhou; Andrew Howard; Laszlo Kiss; Maria L Garcia; Owen B McManus; Qiaolin Deng; Ranjit Desai; Yusheng Xiong; Gregory J Kaczorowski
阅读更多 →

药效评价Cholesterol transport from late endosomes to the Golgi regulates t-SNARE trafficking, assembly, and function.

期刊：Molecular biology of the cell发表年份：2011作者：Meritxell Reverter; Carles Rentero; Sandra Vilà de Muga; Anna Alvarez-Guaita; Vishwaroop Mulay; Rose Cairns; Peta Wood; Katia Monastyrskaya; Albert Pol; Francesc Tebar; Joan Blasi; Thomas Grewal; Carlos Enrich
阅读更多 →